HSP90B2P and cancer: However, constitutive activation of HSF1 does not fully explain HSP overexpression in cancer cells, because genetic knockdown of HSF1 fails to reduce HSP levels in many cancer cell lines to the normal basal levels seen in non-transformed cells [9].